Radiation therapy, also called radiotherapy, is one of the most common methods of treatment for cancer. More than 60 percent of cancer patients undergo radiotherapy at some point during their treatment. With surgery, radiotherapy is the standard of care for local cancer treatment.
Surgery plus radiotherapy improves the prognosis for many patients. However, while radiotherapy can be an effective treatment, the efficacy of treatment may be limited for some patients because the dose required to destroy the tumor may cause too much damage to surrounding healthy tissues.
To meet this unmet need, Nanobiotix is developing NBTXR3, a first-in-class radiohancer composed of hafnium oxide nanoparticles that is designed to destroy tumors when activated by radiotherapy. Clinical data have suggested that when NBTXR3 is activated, it increases the energy absorbed from radiotherapy up to nine times and enhances the dose delivered, inducing significant tumor cell death without increasing the damage to surrounding healthy tissue.
We believe that NBTXR3 activated by radiotherapy may become a new standard of care in the treatment of cancer, potentially helping millions of patients.
Surgery plus radiotherapy improves the prognosis for many patients. However, while radiotherapy can be an effective treatment, the efficacy of treatment may be limited for some patients because the dose required to destroy the tumor may cause too much damage to surrounding healthy tissues.
To meet this unmet need, Nanobiotix is developing NBTXR3, a first-in-class radiohancer composed of hafnium oxide nanoparticles that is designed to destroy tumors when activated by radiotherapy. Clinical data have suggested that when NBTXR3 is activated, it increases the energy absorbed from radiotherapy up to nine times and enhances the dose delivered, inducing significant tumor cell death without increasing the damage to surrounding healthy tissue.
We believe that NBTXR3 activated by radiotherapy may become a new standard of care in the treatment of cancer, potentially helping millions of patients.
Patient Advocacy
We are privileged to be able to in partnership with the following patient advocacy groups who provide crucial support to patients with oral and head and neck cancer. We understand the importance of listening to patients in order to better understand their needs.
France
Corasso
Corasso is a French association that supports and informs people affected by Head and Neck cancer. They help patients during their treatment and when the remission is possible teach them how to live with severe functional and aesthetic consequences. Actives members are also working to support research and contribute to a better quality of life for patients and their loved one. To find out more and access their resources: corraso.org
United Kingdom
The Swallows Head & Neck Cancer Support Group
The Swallows Head & Neck Cancer Support Group is a patient-led organization created to support fellow sufferers and their carers based in the UK. They offer a 24/7 support line and host regular patient meetings. Visit www.theswallows.org.uk to learn more about how patients are supporting other patients.
United States
SPOHNC (Support for People with Oral and Head and Neck Cancer)
It is a nonprofit organization involved in the development of programs of support. It is dedicated to raising awareness and meeting the needs of oral head and neck patients through its resources and publications. It has had an enormous positive impact on meeting the psychosocial needs of patients as well as preserving, restoring, and promoting physical and emotional health. This association has over 125 chapter throughout the United States and continues to grow. To find out more and access their resources: spohnc.org
HNCA (Head and Neck Cancer Alliance)
The mission of HNCA is to advance prevention, detection, treatment and rehabilitation of oral, head and neck cancer through public awareness, research, advocacy and survivorship. Through united and collaborative efforts, HNCA provides support to head and neck cancer patients throughout the year, supports ongoing research in head and neck oncology and educates children and adults in the disease process, treatment and prevention of oral, head and neck cancers. To find out more and access their resources: headandneck.org